Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Ceribell, Inc.CBLL · Entity 4994 | Director | June 02, 2026 | June 04, 2026 |
| TANDEM DIABETES CARE INCTNDM · Entity 4682 | Director | May 20, 2026 | May 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Ceribell, Inc.
Report date June 02, 2026 · Filed June 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 26,587 |
Reported balance
After 2026-06-02 transaction · row 1
1 source rowRow 1 · 2026-06-02 · Grant · Acquired 7,838 · Balance 26,587 F1: Represents restricted stock units ("RSUs"). |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units ("RSUs").
TANDEM DIABETES CARE INC
Report date May 20, 2026 · Filed May 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 22,542 |
Reported balance
After 2026-05-21 transaction · row 1
1 source rowRow 1 · 2026-05-21 · Exercise / conversion · Acquired 8,759 · Balance 22,542 |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 10,220 |
Reported balance
After 2026-05-20 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-20 · Grant · Acquired 10,220 · Balance 10,220 F1: Each restricted stock units (RSU) represents a contingent right to receive either one share of the Issuers common stock or cash in lieu thereof, at the Issuers discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan). F2: Such RSUs were granted to the Reporting Person on May 20, 2026, and will vest on the one-year anniversary thereof, subject to the terms of the 2023 Plan. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-05-21 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-05-21 · Exercise / conversion · Disposed 8,759 · Balance 0 F1: Each restricted stock units (RSU) represents a contingent right to receive either one share of the Issuers common stock or cash in lieu thereof, at the Issuers discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan). F3: On May 21, 2025, the Reporting Person was granted 8,759 RSUs, all of which vested and converted into shares of the Issuers common stock on the one-year anniversary thereof in accordance with the 2023 Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock units (RSU) represents a contingent right to receive either one share of the Issuers common stock or cash in lieu thereof, at the Issuers discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).
F2: Such RSUs were granted to the Reporting Person on May 20, 2026, and will vest on the one-year anniversary thereof, subject to the terms of the 2023 Plan.
F3: On May 21, 2025, the Reporting Person was granted 8,759 RSUs, all of which vested and converted into shares of the Issuers common stock on the one-year anniversary thereof in accordance with the 2023 Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 02, 2026 Filed Jun 4, 2026 21:05 UTC | Ceribell, Inc. CBLL · Entity 4994 | GrantCommon Stock | 7,838 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-257714 · ownership.xml · nonDerivative · entry 1 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,587 F1 · shares: Represents restricted stock units ("RSUs"). Read SEC document |
| May 21, 2026 Filed May 22, 2026 20:06 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 8,759 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-26-000074 · wk-form4_1779480402.xml · derivative · entry 3 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,759 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock units (RSU) represents a contingent right to receive either one share of the Issuers common stock or cash in lieu thereof, at the Issuers discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan). F3 · derivative.exercise_date: On May 21, 2025, the Reporting Person was granted 8,759 RSUs, all of which vested and converted into shares of the Issuers common stock on the one-year anniversary thereof in accordance with the 2023 Plan. F3 · derivative.expiration_date: On May 21, 2025, the Reporting Person was granted 8,759 RSUs, all of which vested and converted into shares of the Issuers common stock on the one-year anniversary thereof in accordance with the 2023 Plan. Read SEC document |
| May 21, 2026 Filed May 22, 2026 20:06 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 8,759 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-26-000074 · wk-form4_1779480402.xml · nonDerivative · entry 1 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,542 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2026 Filed May 22, 2026 20:06 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantRestricted Stock Unit · Derivative | 10,220 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-26-000074 · wk-form4_1779480402.xml · derivative · entry 2 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,220 Underlying: Common Stock · 10,220 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock units (RSU) represents a contingent right to receive either one share of the Issuers common stock or cash in lieu thereof, at the Issuers discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan). F2 · derivative.exercise_date: Such RSUs were granted to the Reporting Person on May 20, 2026, and will vest on the one-year anniversary thereof, subject to the terms of the 2023 Plan. F2 · derivative.expiration_date: Such RSUs were granted to the Reporting Person on May 20, 2026, and will vest on the one-year anniversary thereof, subject to the terms of the 2023 Plan. Read SEC document |
| March 03, 2026 Filed Mar 5, 2026 19:20 UTC | Ceribell, Inc. CBLL · Entity 4994 | SaleCommon Stock | 827 | $17.80 | $14,720.60 |
DisclosureSEC source: 0001193125-26-093506 · ownership.xml · nonDerivative · entry 1 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,749 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 22:16 UTC | Ceribell, Inc. CBLL · Entity 4994 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0001193125-26-004760 · ownership.xml · derivative · entry 3 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,650 Underlying: Common Stock · 2,500 shares Expires 2029-03-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · derivative.exercise_date: The stock option is fully vested and currently exercisable. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 22:16 UTC | Ceribell, Inc. CBLL · Entity 4994 | SaleCommon Stock | 2,500 | $21.89 | $54,725.00 |
DisclosureSEC source: 0001193125-26-004760 · ownership.xml · nonDerivative · entry 2 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 19,576 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 22:16 UTC | Ceribell, Inc. CBLL · Entity 4994 | Exercise / conversionCommon Stock | 2,500 | $2.24 | $5,600.00 |
DisclosureSEC source: 0001193125-26-004760 · ownership.xml · nonDerivative · entry 1 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,076 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| December 08, 2025 Filed Dec 10, 2025 18:02 UTC | Ceribell, Inc. CBLL · Entity 4994 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0001193125-25-313867 · ownership.xml · derivative · entry 3 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,150 Underlying: Common Stock · 5,000 shares Expires 2029-03-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · derivative.exercise_date: The stock option is fully vested and currently exercisable. Read SEC document |
| December 08, 2025 Filed Dec 10, 2025 18:02 UTC | Ceribell, Inc. CBLL · Entity 4994 | SaleCommon Stock | 5,000 | $20.00 | $100,000.00 |
DisclosureSEC source: 0001193125-25-313867 · ownership.xml · nonDerivative · entry 2 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,388 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| December 08, 2025 Filed Dec 10, 2025 18:02 UTC | Ceribell, Inc. CBLL · Entity 4994 | Exercise / conversionCommon Stock | 5,000 | $2.24 | $11,200.00 |
DisclosureSEC source: 0001193125-25-313867 · ownership.xml · nonDerivative · entry 1 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,388 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| December 02, 2025 Filed Dec 4, 2025 19:16 UTC | Ceribell, Inc. CBLL · Entity 4994 | SaleCommon Stock | 827 | $16.67 | $13,786.09 |
DisclosureSEC source: 0001193125-25-307906 · ownership.xml · nonDerivative · entry 1 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,388 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| September 03, 2025 Filed Sep 5, 2025 18:33 UTC | Ceribell, Inc. CBLL · Entity 4994 | SaleCommon Stock | 827 | $11.36 | $9,394.72 |
DisclosureSEC source: 0000950170-25-113220 · ownership.xml · nonDerivative · entry 1 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,215 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| June 18, 2025 Filed Jun 20, 2025 16:31 UTC | Ceribell, Inc. CBLL · Entity 4994 | SaleCommon Stock | 11,188 | $17.85 | $199,705.80 |
DisclosureSEC source: 0000950170-25-088294 · ownership.xml · nonDerivative · entry 2 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,042 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.8 to $17.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 17, 2025 Filed Jun 20, 2025 16:31 UTC | Ceribell, Inc. CBLL · Entity 4994 | SaleCommon Stock | 7,445 | $17.63 | $131,255.35 |
DisclosureSEC source: 0000950170-25-088294 · ownership.xml · nonDerivative · entry 1 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,230 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.01 to $17.9, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 17, 2025 Filed Jan 6, 2026 22:15 UTC Amendment | Ceribell, Inc. CBLL · Entity 4994 | SaleCommon Stock | 7,445 | $17.63 | $131,255.35 |
DisclosureSEC source: 0001193125-26-004759 · ownership.xml · nonDerivative · entry 1 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,230 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.01 to $17.9, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 16, 2025 Filed Jun 17, 2025 23:52 UTC | Ceribell, Inc. CBLL · Entity 4994 | Exercise / conversionStock Option (Right to Buy) · Derivative | 19,455 | $0.00 Strike: $3.65 | $0.00 |
DisclosureSEC source: 0000950170-25-087603 · ownership.xml · derivative · entry 6 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,455 shares Expires 2031-06-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · derivative.exercise_date: The option is fully vested and exercisable as of the transaction date. Read SEC document |
| June 16, 2025 Filed Jun 17, 2025 23:52 UTC | Ceribell, Inc. CBLL · Entity 4994 | Exercise / conversionStock Option (Right to Buy) · Derivative | 545 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0000950170-25-087603 · ownership.xml · derivative · entry 5 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,150 Underlying: Common Stock · 545 shares Expires 2029-03-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · derivative.exercise_date: The option is fully vested and exercisable as of the transaction date. Read SEC document |
| June 16, 2025 Filed Jun 17, 2025 23:52 UTC | Ceribell, Inc. CBLL · Entity 4994 | SaleCommon Stock | 20,000 | $17.14 | $342,800.00 |
DisclosureSEC source: 0000950170-25-087603 · ownership.xml · nonDerivative · entry 4 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,675 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17 to $17.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 16, 2025 Filed Jun 17, 2025 23:52 UTC | Ceribell, Inc. CBLL · Entity 4994 | Exercise / conversionCommon Stock | 19,455 | $3.65 | $71,010.75 |
DisclosureSEC source: 0000950170-25-087603 · ownership.xml · nonDerivative · entry 3 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 48,675 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| June 16, 2025 Filed Jun 17, 2025 23:52 UTC | Ceribell, Inc. CBLL · Entity 4994 | Exercise / conversionCommon Stock | 545 | $2.24 | $1,220.80 |
DisclosureSEC source: 0000950170-25-087603 · ownership.xml · nonDerivative · entry 2 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,220 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| June 10, 2025 Filed Jun 17, 2025 23:52 UTC | Ceribell, Inc. CBLL · Entity 4994 | GrantCommon Stock | 8,828 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-087603 · ownership.xml · nonDerivative · entry 1 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,675 F1 · shares: Represents 8,828 restricted stock units. Read SEC document |
| May 22, 2025 Filed May 23, 2025 20:03 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 4,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-25-000106 · wk-form4_1748030605.xml · derivative · entry 2 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,387 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Awarded on May 22, 2024 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan). F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. F3 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan. F3 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan. Read SEC document |
| May 22, 2025 Filed May 23, 2025 20:03 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 4,387 | $20.64 | $90,547.68 |
DisclosureSEC source: 0001438133-25-000106 · wk-form4_1748030605.xml · nonDerivative · entry 1 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,783 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2025 Filed May 23, 2025 20:03 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantRestricted Stock Unit · Derivative | 8,759 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-25-000106 · wk-form4_1748030605.xml · derivative · entry 3 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,759 Underlying: Common Stock · 8,759 shares Expires not disclosed F4 · security: Awarded on May 21, 2025 pursuant to the 2023 Plan. F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. F3 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan. F3 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan. Read SEC document |
| October 11, 2024 Filed Oct 16, 2024 20:20 UTC | Ceribell, Inc. CBLL · Entity 4994 | GrantCommon Stock | 6,618 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-115010 · ownership.xml · nonDerivative · entry 1 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,847 F1 · shares: Represents 6,618 restricted stock units ("RSUs"). F2 · balance_after: Represents 19,847 RSUs. Read SEC document |
| May 24, 2024 Filed May 24, 2024 23:21 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 4,434 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000121 · wk-form4_1716592892.xml · derivative · entry 3 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,434 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Awarded on May 24, 2023 pursuant to the 2023 Plan. F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. F3 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan. F3 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan. Read SEC document |
| May 24, 2024 Filed May 24, 2024 23:21 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 4,434 | $51.73 | $229,370.82 |
DisclosureSEC source: 0001438133-24-000121 · wk-form4_1716592892.xml · nonDerivative · entry 1 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,396 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2024 Filed May 24, 2024 23:21 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantRestricted Stock Unit · Derivative | 4,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000121 · wk-form4_1716592892.xml · derivative · entry 2 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,387 Underlying: Common Stock · 4,387 shares Expires not disclosed F1 · security: Awarded on May 22, 2024 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan). F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. F3 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan. F3 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan. Read SEC document |
| May 25, 2023 Filed May 26, 2023 20:16 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 2,757 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000109 · wf-form4_168513213829237.xml · derivative · entry 3 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,757 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Awarded on May 25, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan). F5 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F6 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2013 Plan. F6 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2013 Plan. Read SEC document |
| May 25, 2023 Filed May 26, 2023 20:16 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 2,757 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000109 · wf-form4_168513213829237.xml · nonDerivative · entry 1 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,962 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2023 Filed May 26, 2023 20:16 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRSU 2023 05 24 · Derivative | 4,434 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000109 · wf-form4_168513213829237.xml · derivative · entry 2 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,434 Underlying: Common Stock · 4,434 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Awarded on May 24, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan). F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. F3 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan. F3 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan. Read SEC document |
| May 25, 2022 Filed Jun 1, 2022 23:50 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantRestricted Stock Unit · Derivative | 2,757 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000141 · wf-form4_165412741951482.xml · derivative · entry 2 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,757 Underlying: Common Stock · 2,757 shares Expires not disclosed F1 · security: Awarded on May 25, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F3 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2013 Plan. F3 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2013 Plan. Read SEC document |
| May 18, 2022 Filed May 20, 2022 00:00 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 2,205 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000095 · wf-form4_165300479694005.xml · derivative · entry 2 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,205 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F2 · derivative.exercise_price: Each restricted stock (RSU) unit represents a contingent right to receive one share of common stock of the Company. F3 · derivative.exercise_date: Shares will vest on the one year anniversary of the grant date, subject to the terms of the 2013 Plan. F3 · derivative.expiration_date: Shares will vest on the one year anniversary of the grant date, subject to the terms of the 2013 Plan. Read SEC document |
| May 18, 2022 Filed May 20, 2022 00:00 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 2,205 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000095 · wf-form4_165300479694005.xml · nonDerivative · entry 1 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,205 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 02, 2022 Filed May 4, 2022 21:04 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 1,500 | $34.00 Strike: $34.00 | $51,000.00 |
DisclosureSEC source: 0001438133-22-000062 · wf-form4_165169807583447.xml · derivative · entry 4 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,892 Underlying: Common Stock · 1,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option shall vest in 36 equal monthly installments from January 2, 2019, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F6 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| May 02, 2022 Filed May 4, 2022 21:04 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 967 | $97.10 | $93,895.70 |
DisclosureSEC source: 0001438133-22-000062 · wf-form4_165169807583447.xml · nonDerivative · entry 3 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2021. F4 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $96.77 to $97.37. The Reporting Person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| May 02, 2022 Filed May 4, 2022 21:04 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 533 | $96.05 | $51,194.65 |
DisclosureSEC source: 0001438133-22-000062 · wf-form4_165169807583447.xml · nonDerivative · entry 2 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 967 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2021. F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $95.60 to $96.51. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| May 02, 2022 Filed May 4, 2022 21:04 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 1,500 | $34.00 | $51,000.00 |
DisclosureSEC source: 0001438133-22-000062 · wf-form4_165169807583447.xml · nonDerivative · entry 1 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 21:28 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 1,500 | $34.00 Strike: $34.00 | $51,000.00 |
DisclosureSEC source: 0001438133-22-000010 · wf-form4_164392367063084.xml · derivative · entry 5 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,392 Underlying: Common Stock · 1,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option shall vest in 36 equal monthly installments from January 2, 2019, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F7 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 21:28 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 533 | $118.82 | $63,331.06 |
DisclosureSEC source: 0001438133-22-000010 · wf-form4_164392367063084.xml · nonDerivative · entry 4 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2021. F5 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $118.52 to $119.50. The Reporting Person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 21:28 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 667 | $117.89 | $78,632.63 |
DisclosureSEC source: 0001438133-22-000010 · wf-form4_164392367063084.xml · nonDerivative · entry 3 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 533 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2021. F4 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $117.46 to $118.29. The Reporting Person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 21:28 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 300 | $116.63 | $34,989.00 |
DisclosureSEC source: 0001438133-22-000010 · wf-form4_164392367063084.xml · nonDerivative · entry 2 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,200 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2021. F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $116.33 to $116.99. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 21:28 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 1,500 | $34.00 | $51,000.00 |
DisclosureSEC source: 0001438133-22-000010 · wf-form4_164392367063084.xml · nonDerivative · entry 1 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:53 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 1,108 | $34.00 Strike: $34.00 | $37,672.00 |
DisclosureSEC source: 0001438133-21-000199 · wf-form4_163597280304758.xml · derivative · entry 4 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,892 Underlying: Common Stock · 1,108 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option shall vest in 36 equal monthly installments from January 2, 2019, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F6 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:53 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 278 | $136.35 | $37,905.30 |
DisclosureSEC source: 0001438133-21-000199 · wf-form4_163597280304758.xml · nonDerivative · entry 3 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2021. F4 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $136.19 to $136.53. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:53 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 1,222 | $135.64 | $165,752.08 |
DisclosureSEC source: 0001438133-21-000199 · wf-form4_163597280304758.xml · nonDerivative · entry 2 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2021. F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $135.05 to $136.04. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:53 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 1,108 | $34.00 | $37,672.00 |
DisclosureSEC source: 0001438133-21-000199 · wf-form4_163597280304758.xml · nonDerivative · entry 1 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| August 02, 2021 Filed Aug 3, 2021 22:36 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 1,500 | $107.51 | $161,263.95 |
DisclosureSEC source: 0001438133-21-000114 · wf-form4_162803018374811.xml · nonDerivative · entry 1 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 392 F1 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2021. F2 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $107.50 to $107.56. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| June 09, 2021 Filed Jun 10, 2021 20:59 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 500 | $34.00 Strike: $34.00 | $17,000.00 |
DisclosureSEC source: 0001438133-21-000098 · wf-form4_162335875512522.xml · derivative · entry 3 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,000 Underlying: Common Stock · 500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option shall vest in 36 equal monthly installments from January 2, 2019. F4 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.